17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
, Massachusetts, both regions that are headquarters to many other pharmaceutical companies and many academic and research institutions. Competition for skilled
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
. Competition for skilled personnel is intense and the turnover rate can be high, which may limit our ability to hire and retain
highly qualified personnel
424B4
wiqzq ys0
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
g7fu373 jluz72
2 Jun 21
Draft registration statement
12:00am
10-K
yvtptwrdv24j5mi
31 Mar 21
Annual report
2:14pm
424B4
z4ryq6hi oa0gd
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
gk1 m6mux6qw70nqe
23 Jul 20
IPO registration
12:28pm
DRS/A
8pk2os moq
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next